Clinical TrialsSearch results
Number of results: 322
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Japan Erythropoietin Treatment Study for Target Hb and Survival
- Renal anemia under hemodialysis
- Scientific Advisory Committee (SAC)
- 2005-10-01
Other
- MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
- relapsed/refractory multiple myeloma
- Kawai Norisuke
- 2021-08-06
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Recruiting
- Efficacy and safety of PICIBANIL for pleurodesis against pulmonary fistula
- Refractory pneumothorax and postoperative lung fistula
- Ohtaki Yoichi
- 2019-03-15
Completed
- Fibrinolytic therapy with urokinase
- Refractory intrathoracic infection
- Yajima Toshiki
- 2019-03-15
Other
- Safety and efficacy of high-dose leukocytapheresis using a large filter in patients with refractory asthma
- Refractory asthma
- Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine
- 2009-05-02
Other
- Prospective Observational Survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome
- Refractory (drug resistant) nephrotic syndrome
- the Japanese Society of Kidney and Lipids Research
- 2007-11-01
Other
- Phase II study of amrubicin for previously treated advanced non-small cell lung cancer
- Recurrent non-small cell lung cancer
- Gunma University Hospital
- 2009-03-05
Other
- A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.
- Rectal Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-04-01
Other
- Randomized Phase III Trial Comparing surgery-alone to UFT+PSK in Stage II Rectal Cancer
- Rectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01